Vilya-1 Improves Macrocycle Conformation Prediction
DaveJuergens · x · 2026-07-18
Vilya-1 is an all-atom diffusion-based foundation model designed for macrocycle conformation prediction and design. It aims to solve a core bottleneck in drug discovery: stably sampling biologically relevant, low-energy conformations across diverse synthesizable chemical spaces, moving beyond standard peptides.
The authors report that across 66 cyclic peptide X-ray structures, Vilya-1 achieved an 89.2% success rate in generating near-native ring conformations (ring RMSD < 1 Å), significantly outperforming Prime-MCS, RDKit ETKDGv3, Boltz-2/RF3, and several deep learning conformational generators.
The model also generalizes across various macrocycle types and topologies, including:
- Disulfide-linked cyclic peptides
- Sidechain-to-sidechain cyclization
- Tail-to-sidechain cyclization
- Non-peptidic macrocycles, such as macrolides/polyketides
The post also mentions FK506 among the example molecules.
More from Research
- Nature paper images cellular activity across all organs, revealing body-wide circuits — arjunrajlab · 2026-09-11
- Skyfall GS Uses Flux to Refine Gaussian Splatting, Accepted at ECCV 2026 — ducha_aiki · 2026-09-11
- Could 10k agents discover learning methods beyond backprop, or just tweak existing ones? — SeunghyunSEO7 · 2026-09-11
- Apodex Launches TRACES, First Benchmark for Evaluating 'Discoverative AI' on Real-World Problems — Faheem_uh · 2026-09-11
- TRACES grades the process, not the answer: six-dimension eval for open-ended AI science — Faheem_uh · 2026-09-11
- Apodex launches TRACES, a benchmark grading AI on open-ended discovery instead of known answers — Faheem_uh · 2026-09-11